evf_t
EVF Home Page EVF Aims EVF Meetings EVF Membership EVF News EVF Useful Links EVF Contact
 
11th Annual Meeting





 
Google

WWW EVF site
 
Visitor:



Scientific Programme

Preliminary programme (PDF)

Wednesday 23 June 2010

     
14.00 – 16.00   EVF Executive meeting
     
17.00 – 19.00  

EVF Board meeting

 
 

Thursday 24 June 2010

     
07.00  – 09.30  

Set up exhibition

     
09.00 – 10.30  

Registration & coffee/tea/refreshments

     
10.30 – 10.35  

Welcome
Marianne De Maeseneer, President, European Venous Forum

     
10.35 – 12.30  

7th North Sea Meeting on Venous Diseases
(organised by the Benelux Society of Phlebology)
Long-term follow-up after varicose veins treatment
Chair: André van Rij, Cees Wittens

10.35 – 10.50  

Let’s learn something more about statistics
Alun Davies, London, UK

10.50 – 11.10  

What are the long-term outcomes that matter?
Jonothan Earnshaw, Gloucester, UK

11.10 – 11.30  

Long-term follow-up after surgical treatment of varicose veins
Cees Wittens, Maastricht, The Netherlands

11.30 – 11.50  

Long term outcomes after endovenous treatment for varicose veins
Manj Gohel, London, UK

11.50 – 12.10  

Long-term results after redo procedures for recurrent varicose veins
Marianne De Maeseneer, Antwerp, Belgium

12.10 – 12.30  

Defining outcomes: Pitfalls and possibilities
André van Rij, Dunedin, New Zealand

     
12.30 – 13.00   General assembly of the Benelux Society of Phlebology
(only for members of BSP)
     
12.30 – 13.30   Lunch
     
13.30 – 14.50  

Prevention of venous thromboembolism (VTE) in 2010: an update
Chair: Niels Baekgaard, Ajay Kakkar

13.30 – 13.50  

Risk assessment as a guide to thrombosis prophylaxis. 
Joe Caprini, Chicago, USA

13.50 – 14.10  

New perspectives in pharmacologic prophylaxis
Ajay Kakkar, London, UK

14.10 – 14.30  

Intermittent pneumatic compression and combined modalities for VTE prevention in high risk patients
Andrew Nicolaides, Nicosia, Cyprus         

14.30 – 15.30  

Treatment of VTE: improving the long-term outcome
Chair: Niels Baekgaard, Ajay Kakkar

14.30 – 14.50  

Advances in anticoagulant treatment of VTE
Russell Hull, Calgary, Canada

14.50 – 15.10  

Generic and biosimilar anticoagulants; what does the future hold?
Jawed Fareed, Loyola University, Maywood, IL, USA

15.10-15.30  

Long-term results after catheter-directed thrombolysis for iliofemoral deep vein thrombosis
Anthony Comerota, Toledo, Ohio, USA

     
15.30 - 16.00   Coffee break / Visit of exhibition
     
16.00-17.15  

Invited Presentations
Chair: Joe Caprini, Bo Eklof

16.00 – 16.40  

Presentations from the American Venous Forum (Servier Award Travelling Fellowship winners)

  Paper No
16.00 – 16.20 A1

Post thrombotic vein wall remodeling: preliminary findings.
K Deatrick, N Baker, S DeRoo, MA Elfline, V Sood, C Stabler, SA Blackburn, CE Luke, TW Wakefield, PK Henke.  University of Michigan, Ann Arbor, MI, USA

                       
16.20 – 16.40 A2

Validation of the Caprini Risk Assessment Model in Plastic and Reconstructive Surgery Patients.
CJ Pannucci(1), S Bailey (2), C Fisher(3), J Clavijo-Alvarez (3), J Hamill
(4), K Hume(4), T Wakefield (1), J Rubin (3), E Wilkins (1), R Hoxworth(2). 
(1) University of Michigan, Ann Arbor, MI,
(2) University of Texas-Southwestern, Dallas, TX,
(3) University of Pittsburgh, Pittsburgh, PA,
(4) American Society of Plastic Surgeons, Arlington Heights, IL, USA

16.40 – 17.00 A3

Presentation from the EVF Travelling Fellowship 2009
Incidence of secondary interventions after endovenous laser therapy and
minimal phlebectomies for the treatment of varicose veins.
G Sfyroeras.  Department of Vascular Surgery, University Hospital of Larissa, Larissa, Greece

17.00 – 17.15  

Reduction of venous ulcers by 50% in ten years in the US – is that feasible? Report from the 6th Pacific Vascular Symposium in Hawaii November 2009
Bo Eklof.  Sweden

17.15-18.00  

Duplex ultrasound scan in phlebologic practice: tips and tricks (life cases)
Nicos Labropoulos, Stony Brook, New York, USA

     
18.00 – 19.15  

Session 1.  Short Papers (5 min + 10 min discussion)

  Paper No
18.00 1.1

Surgical treatment for varicose recurrence: Is inguinal redo surgery justified?
Pittaluga P1,2, Chastanet S1,2, Locret T1, Rousset O2. 
1 Riviera Veine Institut, Nice, France.  1 -IM2S, Monte-Carlo, Monaco

18.15 1.2

Quality assurance of venous duplex scans performed by a vascular surgeon.
Kordowicz A, Ferguson G, Salaman R, Onwudike M. 
Department of Vascular Surgery, Royal Bolton Hospital, England
Submitted in consideration for the EVF Prize

18.30 1.3

Analyzing exhaled breath during endovenous laser ablation of varicose veins using an electronic nose and gas chromatography-mass spectrometry.
Gauw SA, Fens N, Knobel HH, Bokx de PK, Vlijmen van CJ, Sterk PJ. 
Flebologisch Centrum Oosterwal, Alkmaar, The Netherlands. 
Department of Pulmonology, Academic Medical Centre, Amsterdam, The Netherlands. 
MiPlaza TMA, Philips Research Europe, Eindhoven, The Netherlands

18.45 1.4

Pharmacodynamic differences between biosimilar and branded enoxaparins with reference to their immunogenic profile.
Ramacciotti E, Rao G, Hoppensteadt D, Jeske W, Walanga JM, Fareed J.
Pathology, Loyola University Medical Center, Maywood, IL, United States of America. University of Michigan, Ann Arbor, MI, USA

19.00 1.5

Microfoam sclerotherapy as a part of multimodality treatment in patients with venous malformations.
Sapelkin SV, Dan VN, Vetyugova LV. 
Vishnevsky Institute of Surgery,Moscow, Russia
Submitted in consideration for the EVF Prize

     
19.30 – 21.00   Welcome reception at exhibition area
 
top

Friday 25 June 2010

     
08.00 – 08.30  

Registration & coffee/tea/refreshments

     
08.25  

Welcome
Andrew Nicolaides, Chairman of the European Venous Forum

     
8.30 – 10.30  

Session 2: Clinical and Basic Research(6 papers: 10 min + 10 min discussion)
Chair: Andrew Nicolaides, Marianne de Maeseneer

  Paper No
08.30 2.1

Reproducibility of lower limb venous reflux assessed by ultrasound
duplex scanning using manual and pneumatic cuff compression in
patients with chronic venous disease and controls.
Broholm R, Jensen LP, Sillesen H, Bækgaard N. 
Department of Vascular Surgery, Rigshospitalet, Department at Gentofte Hospital, University of Copenhagen, Denmark.
Submitted in consideration for the EVF Prize

08.50 2.2

Perforator incompetence and associated patterns of saphenous reflux in
primary chronic venous disease.
Qureshi MI, McDonald A, Wing L, Lim CS, Gohel M, Ellis M, Franklin IJ, Davies AH. 
Imperial Vascular Unit, Charing Cross Hospital, Imperial College London, United Kingdom
Submitted in consideration for the EVF Prize

09.10 2.3

Lower limb venous blood flow by Magnetic Resonance Imaging during
Intermittent Pneumatic Compression of the Calf and Foot.
Pierce I1,3, Kalodiki E2,3, Lattimer C2,3, Geroulakos G2,3, Gatehouse PD1,3, Firmin DN1,3. 
Cardiovascular MR Unit Royal Brompton Hospital Trust1,
Vascular Unit Ealing Hospital2, Imperial College London3
Submitted in consideration for the EVF Prize

09.30 2.4

Tissue pressures in venous disease.
Gemayel G, Christenson JT. 
Division of Cardiovascular Surgery, Venous Centre, University Hospital of Geneva & Faculty of Medicine, University of Geneva, Geneva, Switzerland
Submitted in consideration for the EVF Prize

09.50 2.5

Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors.
Pollice F, Pollice P, Groehe B. 
University of Berne, Department of Cardiology and Biology, Switzerland

10.10 2.6

Steam ablation of saphenous varicose veins: A promising new endovenous thermal therapy.
van den Bos RR, Milleret R, Neumann M, Nijsten T.  Erasmus MC, Rotterdam,
The Netherlands
Submitted in consideration for the EVF Prize

     
10.30 – 11.00   Coffee break / Visit of exhibition
     
11.00 – 12.20   Long-term oedema needs long-term compression
Chair: Hugo Partsch, Karin van der Wegen
11.00 – 11.20  

Compression to control oedema: Bandages or stockings?
Giavanni Mosti, Lucca, Italy

11.20 – 11.40  

What about occupational oedema?
Hugo Partsch, Vienna, Austria

11.40 – 12.00  

What about post-thrombotic oedema?
Martino Neumann, Rotterdam, The Netherlands

12.00 – 12.20  

What about lymphoedema?
Robert Damstra, Drachten, The Netherlands

     
12.20 – 12.50  

EVF Invited Lecture
Current Advances in the Treatment of Post-Thrombotic Syndrome
Russell Hull, Calgary, Canada

     
12.50 – 13.30   Lunch
     
13.30 – 15.30   Session 3.  Deep Venous Problems (6 papers: 10 min + 10 min discussion)
Chair: Michel Perrin, Ivan Staelens
  Paper No
13.30 3.1

Perioperative bridging therapy in surgical patients with high risk of
thromboembolic and haemorrhagic complications on long term
acenokumarol therapy.
Wiszniewski A¹, Szopiński P¹, Bilski R¹, Proniewski J², Ratajczak J³
¹Department of Vascular Surgery, Institute of Hematology and Transfusion
Medicine, Warsaw, Poland. 
²Department of Radiology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland. 
³Department of Anesthesiology and Intensive Care, Institute of Hematology and
Transfusion Medicine, Warsaw, Poland
Submitted in consideration for the EVF Prize

13.50 3.2

Effect of the anticoagulant therapy in the thrombus regression: A prospective duplex ultrasound study.
Romera-Villegas A, Cairols MA,  Martí-Mestre X, Riera-Batalla S, Martinez-Rico C. 
Servei d’Angiologia i Cirurgia Vascular, Hospital Universitary de Bellvitge, Barcelona, Spain
Submitted in consideration for the EVF Prize

14.10 3.3

A ten year experience of retrievable inferior vena cava filters.
Ahmad A1, Saha P1, Rolph R1, Patel AS1, Modarai B1, Sabharwal T2, Waltham M1.  1Department of Vascular Surgery, Guy’s and St Thomas’ NHS Foundation Trust, King’s Health Partners, London, UK. 
2Department of Interventional Radiology, Guy’s and St Thomas’ NHS Foundation Trust,  London, UK

14.30 3.4

Towards a better understanding of inferior vena cava atresia.
Lauwers K, Hertoghs M, Van Schil P, De Maeseneer M. 
Antwerp University Hospital, Department of Thoracic and Vascular Surgery, Antwerp, Belgium
Submitted in consideration for the EVF Prize

14.50 3.5

Stenting for chronic postthrombotic vena cava and iliofemoral venous
occlusions.  Midterm patency and clinical outcome.
Rosales A1, Sandbæk G1,2, Jørgensen JJ1,2. 
Dept. Of Vascular  Surgery, Oslo University Hospital, Aker1, 
University of Oslo, Norway2

15.10 3.6

Percutaneous occlusion in deep parallel reflux after deep venous valve reconstruction.
Maleti O, Lugli M, Guerzoni S. 
Department of Cardiovascular Surgery, Research and Management Center for Deep Vein Disorders, Hesperia Hospital, Modena, Italy

     
15.30 – 16.00  

Coffee break

     
16.00 – 18.00   Session 4: Endovenous Treatment of Varicose Veins: Clinical Trials
Chair: Jonothan Earnshaw, Anja Sommer
  Paper No
16.00 4.1

A prospective recovery study after high ligation and stripping or endovenous treatment of the insufficient great saphenous vein using local anaesthesia.
Pronk P, Gauw SA, Mooij MC, Gaastra MTW, Lawson JA, van Vlijmen-van Keulen CJ.  Flebologisch Centrum Oosterwal, Alkmaar, The  Netherlands
Submitted in consideration for the EVF Prize

16.20 4.2

Endovenous laser treatment: is there a different clinical and
morphological outcome using a 1500nm laser versus a 980 nm diode laser? A multicentric randomised comparative trial.|
Vuylsteke M (1), De BO Th (1), Dompe G (2), di Crisci D (2), Miquel Abbab C (3),
Mordon S (4).
(1) Department of Vascular Surgery, Sint-Andriesziekenhuis, Tielt, Belgium.
(2) Department of Vascular Surgery, Istituto Dermopatico Dell’Immacolata, Rome, Italy.  (3) Department of Vascular Surgery, Hospital Universitari Sagrat Cor, Barcelona, Spain.  (4) INSERM U703, Lille University Hospital, Lille, France                 

16.40 4.3

Randomised clinical trial comparing VNUS Closure Fast versus laser for varicose veins (VALVV): Duplex and quality of life outcomes at 6 months.
Shepherd AC, Gohel MS, Brown LC, Davies AH. 
Imperial Vascular Unit,Imperial College, London, UK
Submitted in consideration for the EVF Prize

17.00 4.4

Comparison of radiofrequency and laser treatment in the same saphenous veins of the same patient.
Ragg JC, Martel L, Wolschner J, Nagy J. 
Angioclinic, Berlin, Germany

17.20 4.5

Duplex guided foamsclerotherapy vs surgery for the incompetent great
saphenous vein: a randomised controlled trial.
Shadid N, Nelemans P, Sommer A. 
Maastricht University Medical Center (MUMC), Maastricht, The Netherlands
Submitted in consideration for the EVF Prize

17.40 4.6

Randomized trial comparing RF, Laser, foam sclerotherapy and stripping in varicose veins.
Lawaetz M, Rasmussen LH, Bjoern L, Blemings A, Eklöf B. 
The Danish Vein Centres and Surgical Centre Roskilde, Naestved, Denmark
Submitted in consideration for the EVF Prize

     
18.00 – 18.30   General Assembly of the European Venous Forum
     
19.15    Short walk to the boat
     
19.30 – 24.00 …  

Dinner cruise on river Scheldt with the ‘Seastar’

 
top

Saturday 26 June 2010

     
08.00  – 9.00   Registration & coffee/tea/refreshments
     
09.00 – 11.00  

Session 5.  Socio-economic Implications of Chronic Venous Disease
Chair: Attilo Cavezzi, Martino Neumann

  Paper No
09.00 5.1

How well informed are your patients?  Assessing the quality of varicose vein information for patients on the internet.
Neffendorf JE1, Soobrah R2, Grewal P3. 
1University College London Hospital, London, UK.
2Northwick Park and St. Paul’s Hospitals, London,UK.
3Royal Free Hospital, London, UK
Submitted in consideration for the EVF Prize

09.20 5.2

Validating veines QOL/SYM: Measuring changes following endovenous microfoam ablation of the Great Saphenous vein.
Gibson K, Wright D, Rush J, Suplick G, Evans E. 
Lake Washington Vascular Surgeons, Bellevue, WA, USA

09.40 5.3

Varicose vein recurrence and patient satisfaction 10-15 years following saphenous and perforator surgery.
Nelzén O,
Depts Vascular Surgery, Skaraborg Hospital/KSS, Skövde & Uppsala University, Sweden

10.00 5.4

Hospital admission for venous ulcers: What is it worth?
Reeder SWI1, de Roos K-P2, de Maeseneer M3, Sommer A4, Neumann HAM1. 
1Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands, 
2Department of Dermatology, DermaPark, Uden, TheNetherlands,
3Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Antwerp, Belgium,
4Department of Dermatology, Academic Hospital Maastricht, Maastricht, The Netherlands
Submitted in consideration for the EVF Prize

10.20 5.5

Can saphenous and sural nerve paraesthesia be prevented during ELT?
King T1 
1Vein Clinics of America, Oak Brook, IL, USA

10.40 5.6

The cost effectiveness of the Trellis Peripheral Infusion System (“Trellis”) compared with Catheter Directed Thrombolysis or treatment with standard anticoagulation therapy for patients who are poor responders to ACT: An exploratory Markov analysis
O’Sullivan GJ.  Galway
University Hospitals & National University of Ireland in Galway, Galway, Ireland

     
11.00 – 11. 30  

Coffee break / Visit of exhibition
After break: end of exhibition

     
11.30 – 12.30   Back to basic science…
Chair: Marc Cairols, Mieke Flour
11.30 – 11.50  

Casting around for new ideas in venous physiology
André van Rij, Dunedin, New Zealand

11.50 – 12.10  

The scientific basis for the management of chronic venous disease
Anthony Comerota, Toledo, Ohio, USA

12.10 – 12.30  

Studying the skin in chronic venous disease
Mieke Flour, Leuven, Belgium

     
12.30 – 12.45   Musical intermezzo
Conducted by Prof Joost Weyler, University of Antwerp
     
12.45 – 13.00  

Presentation of EVF prizes - farewell

top

    Last updated: 25-May-2010  
  © Copyright 2006 - European Venous Forum - All rights reserved
Created by: ek